Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02614196
Brief Title: Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study (EVOLVE-2)

First Submitted : November 23, 2015
First Submitted that Met QC Criteria : November 23, 2015
First Posted : November 25, 2015 (Estimate)

Results First Submitted : August 23, 2018
Results First Submitted that Met QC Criteria : December 12, 2018
Results First Posted : January 7, 2019

Certification/Extension First Submitted : March 15, 2018
Certification/Extension First Submitted that Met QC Criteria : March 15, 2018
Certification/Extension First Posted : March 19, 2018

Last Update Submitted that Met QC Criteria : June 10, 2020
Last Update Posted : June 17, 2020